CBD and THC Can Share Mass-Spectrometry Fragments Without Showing Conversion in the Body
Matching mass-spectrometry fragments do not, by themselves, distinguish CBD from THC. A laboratory experiment found that the two compounds produced identical fragmentation spectra under positive electrospray ionization. The proposed explanation involved reactions inside the instrument’s ion source; the study did not test whether a person converts swallowed CBD into THC.
What the experiment actually contained
Broecker and Pragst investigated reference solutions of CBD and delta-9-THC using flow-injection quadrupole time-of-flight mass spectrometry. They compared positive and negative electrospray conditions and used hydrogen/deuterium exchange to investigate the behavior of the resulting ions.
This was analytical chemistry involving prepared solutions. There were no human participants, animal dosing groups, blood specimens, urine specimens or biological cell cultures in the reported experiment. Its findings concern identification inside an analytical system.
Why accurate mass and multiple fragments were insufficient
CBD and THC are isomers. In the tested positive-ion conditions, their collision-induced fragmentation spectra matched even though the starting molecules had different structures. The researchers observed exchange of hydrogen at carbon-bound positions as well as at hydroxyl groups.
They interpreted that pattern as evidence of acid-catalyzed equilibration in the positive electrospray source. The paper did not establish which single structure, or mixture of structures, predominated among the ions submitted to fragmentation. It also noted that some exchange yields were not fully reproducible, limiting mechanistic conclusions drawn from differences in fragment abundance.
The practical implication is specific: adding another matching fragment or an apparently acceptable fragment-intensity ratio cannot resolve every identification problem when two compounds produce the same positive-ion pattern. These observations do not mean every cannabinoid assay is inaccurate.
Chromatographic retention time supplies different evidence
Liquid chromatography can separate compounds before they enter the mass spectrometer. The time at which a compound emerges therefore provides information distinct from the fragments generated afterward. The authors concluded that retention time or other experimental evidence was needed to distinguish CBD and THC unambiguously under the positive-ion conditions they examined.
Negative electrospray produced different fragmentation patterns for the two compounds in this work. That contrast helps localize the finding to the tested analytical conditions; it does not automatically validate a different laboratory’s complete method, specimen preparation or identification rules.
What the study means for a disputed THC result
A useful review would ask whether the laboratory demonstrated separation of CBD and THC, matched retention times against suitable reference material, and applied validated identification criteria to the actual specimen matrix. A shared transition alone is insufficient evidence that the compounds were confused in a particular case. Conversely, a mass-spectrometer model name cannot substitute for the chromatograms and validation records.
The experiment supplies no frequency of false positives in real patients and no numerical correction to apply to a reported THC concentration. It also supplies no evidence of intoxication, impairment or a biological conversion rate. For the separate question involving administered CBD and human samples, see human CBD-conversion research and chromatographic separation.
Primary research
Sebastian Broecker and Fritz Pragst. Rapid Communications in Mass Spectrometry (2012), 26:1407–1414. Isomerization of cannabidiol and delta-9-tetrahydrocannabinol during positive electrospray ionization.
